The variant affects gene DTYMK (deoxythymidylate kinase), which is on Chromosome 2. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Neurodegeneration, childhood-onset, with progressive microcephaly